Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NOTICE OF ANNUAL GENERAL MEETING IN GENOVIS AB

Genovis AB will hold its Annual General Meeting of Shareholders at 3:00 p.m. on Tusday, May 5, 2020 at Scheelevägen 2 (Medicon Village) in Lund. Participants may register upon arrival at the reception desk by the main entrance. To reduce the risk of spreading the corona virus, Genovis’ 2020 AGM will be kept brief and will be held without any reception or food and drink afterwards.  2:30 p.m. – 2:50 p.m. Registration                      3:00 pm Annual General Meeting convenedRight to participate. Registration Shareholders who are registered in the register of shareholders

Instalco wins assignment for work at hospital on behalf of NCC and Region Sörmland

The Instalco companies, Rörgruppen and Ohmegi have won an assignment from NCC for the electrical, heating & plumbing installations in conjunction with the expansion of three hospitals in Södermanland. The work will be carried out as part of a collaboration project and the total order value is approximately SEK 700 million during the period 2020-2026.Rörgruppen and Ohmegi will also engage the following Instalco subsidiaries as subcontractors: El & Säkerhet, JN El, Sprinklerbolaget and LG Contracting. “Instalco, with the accumulated expertise of its many subsidiaries, has extensive

MasterTig and Flexlite awarded with the Red Dot Product Design Award

Kemppi’s MasterTig welding equipment and Flexlite TX welding torch have been awarded with the distinguished Red Dot Product Design Award. Both solutions are developed and designed in Finland and represent the utmost user experience and ergonomy. MasterTig – Far from the ordinary Kemppi’s MasterTig sets new standards for weld quality, usability, and power efficiency in AC and DC TIG welding. Designed for professional welders, the MasterTig product family’s modular design philosophy allows to build the specification that best meets welder’s needs, including alternative control panels,

Annual Report 2019

Vitrolife has today published its Annual Report for 2019. The document is attached to this press release and is also available on www.vitrolife.com .Distribution of the printed versions of the Annual Reports to those shareholders who have requested dispatch, will be done by mail during the week commencing 6 April. The printed version of the Annual Report can be ordered on the company's website www.vitrolife.com , by phone +46 (0)31 721 80 00 or by email info@vitrolife.com. Gothenburg, SwedenMarch 30, 2020VITROLIFE

Cereno Scientific's Phase II clinical trial postponed due to Covid-19

Due to the global spread of the Sars-cov-2 virus Cereno Scientific announces that the company will postpone the planned Phase II clinical trial with the company’s lead compound CS1. The start of the study was previously planned for mid-year 2020. Cereno Scientific is adjusting planned activities to start by the end of the year, but is prepared for further adjustments if needed, due to the uncertainty of the further development of the pandemic.Given the current situation, there are no possibilities to start the Phase II study in elective orthopedic surgery, as planned knee joint surgery is

ANNOUNCEMENT OF THE NAV OF PROVENTUS CAPITAL PARTNERS IV B

Today the Net Asset Values of the Proventus Capital Partners IV B participation loan debentures are being announced. At the close of business on 27 March, the Net Asset Value of the series A1 participation loan debentures amounted to EUR 102.72 each, and the Net Asset Value of the series B participation loan debenture amounted to EUR 1,035.1 each. The Net Asset Value of Proventus Capital Partners IV B participation loan debentures is to be calculated at the close of each quarter and in conjunction with a capital increase or decrease. The Net Asset Value has been set as a result of

CapMan Buyout invests in PDSVISION

CapMan Buyout’s fund CapMan Buyout XI has entered into an agreement to invest in leading industrial software solutions provider PDSVISION. CapMan acquires a majority equity share in the company, with key members of the PDSVISION organization retaining a significant share. CapMan Buyout will partner with the PDSVISION team to continue to support its accelerated growth and expansion of the group. The investment is the first of the CapMan Buyout XI fund, which was established in 2019. PDS Vision Group (PDSVISION), was founded in 2008 and is the leading provider of software solutions and

Metsä Group’s investment projects in Finland progress – the world’s most modern sawmill will be built in Rauma

Metsä Group press release 30 March 2020 at 10:00 EETMetsä Fibre, part of Metsä Group, has made the decision to build the world’s most modern sawmill in Rauma. The value of the investment is approximately EUR 200 million. Construction will begin in the spring of 2020. Production at the sawmill is set to begin during the third quarter of 2022. The coronavirus outbreak may have an impact on the schedules. The pre-engineering phase of the Kemi bioproduct mill continues, and Metsä Group expects to be ready to make a decision on this approximately EUR 1.5 billion mill in the autumn of 2020.

Bonava AB’s AGM – Updated proposal from the Nomination Committee

In the light of Covid-19, Bonava AB’s Nomination Committee has decided to withdraw its proposal of increased board fees (item 12 on the agenda) to Bonava’s AGM, March 31, 2020.  The Nomination Committee of Bonava AB are instead proposing that the AGM resolves that the current board fees remain unchanged this year. The Nomination Committee’s other proposals remain unchanged. For more information, please contact:   Louise Tjeder, Head of IRlouise.tjeder@bonava.comTel: +46 707 826 374     Bonava is a leading residential development company in Northern Europe that has been

Wärtsilä signs agreement with Kuribayashi Steamship in Japan for deployment of innovative gate rudder technology

Wärtsilä Corporation, Trade press release, 30 March 2020 at 10 am EET· Gate rudder technology lowers fuel consumption and reduces emissions · Better manoeuvrability & course stability in both calm and rough seas · An innovative design that reduces noise and vibrations The technology group Wärtsilä, with the consent of all joint Japanese patent holders developing gate rudder technology, has announced the signing of a Licence and Co-operation Agreement with Kuribayashi Steamship Co for future development, sales and servicing of the gate rudders. In addition to Kuribayashi Steamship

ANNOUNCEMENT OF THE NAV OF PROVENTUS CAPITAL PARTNERS IV

Today the Net Asset Values of the Proventus Capital Partners IV participation loan debentures are being announced. At the close of business on 27 March, the Net Asset Value of the series A1 participation loan debentures amounted to EUR 104.07 each. The Net Asset Value of Proventus Capital Partners IV participation loan debentures is to be calculated at the close of each quarter and in conjunction with a capital increase or decrease. The Net Asset Value has been set as a result of Proventus Capital Partners IV increasing its contributed capital by EUR 11.6 million through the issuance

Inhalation Sciences: five key features driving DissolvIt market launch

Inhalation Sciences recently shipped two newly commercialized DissolvIt[®] units to two customers—in just one week. What are the new and optimized features in this final market version that help make DissolvIt[®][ ]so much in demand? ISABs in vitro specialist and Director of Projects Maria Malmlöf explains.ONE: USABILITY “I’ve run the new system many times now and it feels very smooth-running and luxurious compared to the prototype” says Maria Malmlöf, ISAB’s Director of Projects, “it’s easier to handle, looks far better in design, and there’s precision and automation in every step and

EG7 presents information update for multiple titles in April 2020

Due to that Game Development Conference (GDC), which would have taken place in March 2020 and where EG7 would present more information regarding multiple titles, has been cancelled, EG7 will instead present information about the titles in April 2020. The update regards mainly the titles EvilvEvil, Project Anubis and ’83. FOR MORE INFORMATION, PLEASE CONTACT: Robin Flodin, CEO Phone: +46 70 477 06 34 robin@enadglobal7.com Alexander Albedj, Chairman Phone: +46 76 221 30 75 alex@enadglobal7.com ABOUT EG7 EG7 is a group of companies within the gaming industry that

CEO: ”Our group is resilient and we adapt to the development day by day”

Our world faces major challenges and our group must adapt to the prevailing circumstances and contribute in minimizing the risk of spreading the corona virus. We want to be as transparent as possible about how and where we are affected, but also tell you that our capacity and ability to deliver are unchanged in many ways.In many aspects, ‘business as usual’ prevails in the Lesjöfors companies, but some countries have introduced strict regulations that affect us. We have activated a carefully prepared emergency plan both at group level and in every company. We follow the development globally

K-Fastigheter plan for more apartments in Kristianstad

K-Fast Holding AB has signed an agreement on the acquisition of the Hammar 9:197 property in the popular C4 area in Kristianstad. Estimates indicate that the site is suitable for construction of two Apartment Blocks with about 48 apartments and a lettable area of 3,101 square meters.K-Fast Holding AB (“K-Fastigheter”), an active and committed landlord offering attractive homes in southwestern Sweden, has signed an agreement on the acquisition of the shares in Fastigheten i Hammar 9:197 AB. The acquired company has signed land allocation agreement with Kristianstad Municipality regarding the

Invitation to the Annual General Meeting of shareholders of I.A.R. Systems Group AB (publ)

The shareholders of I.A.R. Systems Group AB (publ) (the “Company” or “IAR Systems”) are hereby invited to attend the Annual General Meeting of shareholders to be held on Wednesday, April 29, 2020 at 6:00 p.m. at Spårvagnshallarna, Birger Jarlsgatan 57 A, Stockholm, Sweden.Notification, etc.Shareholders who wish to participate in the Annual General Meeting (“AGM”) must: – be recorded in the share register maintained by Euroclear Sweden AB not later than Thursday, April 23, 2020, and– provide notification of their intention to participate in the AGM not later than Thursday, April 23,

PowerCell receives order for PowerCell S3 from Bosch at a total value of MSEK 11.5

PowerCell Sweden AB has received an order for PowerCell S3 fuel cell stacks from Bosch at a total value of approximately MSEK 11.5 (1,047,900 Euro). The order will have a positive financial impact during the first quarter 2020.The order comprises several PowerCell S3 fuel cell stacks to be delivered to Bosch within the framework of the joint development and licensing agreement. In April last year German Robert Bosch GmbH and PowerCell Sweden signed an agreement regarding the development, production and sale of the PowerCell S3 fuel cell stack for the automotive segment. The agreement

Withdrawal of Dividend Proposal and Unchanged Board fees

The Saab Board of Directors confirms its assessment of the company’s dividend capacity for the financial year 2019 but due to the uncertainty the COVID-19 outbreak creates in the surrounding world, the Board has decided to withdraw its dividend proposal to the Annual General Meeting. When the situation can be better analysed, the Board can assess the possibility of a new dividend proposal for 2019.Saab’s Annual General Meeting is to take place on April 1, 2020. In its dividend motivation, the Saab Board of Directors assesses the company’s 2019 dividend capacity to not affect Saab’s ability

Catena’s Annual Report for 2019 has been published

30 March 2020, 08:30 a.m. CETCatena’s Annual Report for 2019 has now been published on the company´s website, www.catenafastigheter.se/investerare/rapporter/. The Annual General Meeting will be held in Stockholm on 29 April 2020. Printed copies of the Annual Report will be available on order in April by email info@catenafastigheter.se. Both the Swedish original and an English translation of the Annual Report are available from today on Catena’s website.   For further information, please contactBenny Thögersen, CEO                                           Tel. +46 706-60 83

CircleK extends relationship with Zalaris for European Payroll and HR services

Zalaris ASA announced the renewal of its agreement with CircleK to deliver European Managed Payroll and HR services for another five-year term.The new agreement includes the provision of managed payroll and HR services for CircleK’s more than 14,000 employees in Norway, Sweden, Denmark, Estonia, Latvia, Lithuania, Poland and Ireland. Services will continue to be powered by Zalaris’ proven Multi-Country Cloud solution for payroll, time, travel expenses and digital personnel archive with portal and mobile self service for HR professionals, managers and employees.  As part of the agreement,

Imfinzi approved in the US for extensive-stage small cell lung cancer

30 March 2020 07:00 BST  Imfinzi approved in the US for extensive-stage small cell lung cancer  Only PD-1/PD-L1 immunotherapy to demonstrate a significant survival benefit in combination with etoposide and a choice of carboplatin or cisplatin chemotherapy  AstraZeneca's Imfinzi (durvalumab) has been approved in the US as a 1st-line treatment for adult patients with extensive-stage small cell lung cancer (ES-SCLC) in combination with standard-of-care (SoC) chemotherapies, etoposide plus either carboplatin or cisplatin (platinum-etoposide).  The approval by the Food and

Farxiga Phase III DAPA-CKD trial will be stopped early after overwhelming efficacy in patients with chronic kidney disease

30 March 2020 07:00 BST Farxiga Phase III DAPA-CKD trial will be stopped early afteroverwhelming efficacy in patients with chronic kidney disease   Farxiga is the first SGLT2 inhibitor to show meaningful benefit in patients with chronic kidney disease in a trial including both type-2 diabetics and non-diabetics The Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) Phase III trial for Farxiga (dapagliflozin) in patients with chronic kidney disease (CKD) will be stopped early following a recommendation from an independent Data Monitoring

There are no items matching the current filter
There are no more items matching the current filter
Back to top